ARG1 and neoplasm: CB-1158, an arginase 1 inhibitor synthesized at Calithera Biosciences blocked myeloid cell-mediated suppression of T cell proliferation in vitro and reduced tumor growth in several mouse models of non-CNS tumors (CT26, LLC, B16, and 4T1 tumors).